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ABSTRACT

Author: Bayer, Kelsey, C. MSBME
Institution: Purdue University
Degree Received: December 2017
Title: Design of a small, affordable low intensity focused ultrasound device for vagus nerve
stimulation
Major Professor: Pedro Irazoqui

Depression is a serious public health issue that affects more than 300 million people
worldwide. While there are antidepressant drugs to alleviate depressive symptoms, 10 – 30% of
patients either do not respond or develop a tolerance to these drugs. Researchers have found a
correlation between the inflammatory response and treatment-resistant depression (TRD).
Blocking this inflammatory pathway with electrical vagus nerve stimulation (VNS) can reduce
cytokine levels and depressive symptoms. However, placing an electrical VNS device is
invasive, costly, and poses a risk to the vagus nerve. Low intensity focused ultrasound (LIFU) is
a novel therapy that is able to both excite and suppress neuronal activity in neurological
disorders. However, progression of this research area has been impeded by the size and price of
these devices. I designed a 50 x 57 x 76 mm LIFU device that consists of a transducer, matching
network, and amplification network. Next, I characterized my LIFU device with 2D intensity
maps of the focused ultrasound (FUS) field. My device produced an instantaneous intensity up to
350 mW/cm2. My colleagues and I applied the LIFU device on Sprague-Dawley rats (n=12) for
VNS with the primary goal of reducing the inflammatory response. Five out of the eight rats that
we analyzed showed a decrease in the cytokine TNF-α. Future work will involve design
improvements and more animal studies with varying stimulation parameters. As FUS technology
becomes smaller we move closer to wearable devices. As FUS technology becomes more
affordable more research groups will have the opportunity to employ this novel therapy to
investigate the pathophysiology of neurological disorders.
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1. INTRODUCTION

1.1. The Role of the Inflammatory Response in Depression
Depression is a serious public health issue that affects more than 300 million people
worldwide [1]. This disorder can have a debilitating effect on a person’s everyday life and can
lead to suicide. Around 800,000 people commit suicide every year with this being the second
leading cause of death in 15 to 29 year olds [1]. In 2010, approximately $210.5 billion dollars
was spent directly and indirectly on depression. The categorical break down for this staggering
number is based on work-place productivity, healthcare, and suicide related costs [2]. To better
understand depression it is important to look into the pathophysiology. The monoamine
hypothesis poses that depressive symptoms are the result of a deficiency in neurotransmitters
such as serotonin, norepinephrine, and/or dopamine[3]–[5]. Antidepressant drugs, such as
selective serotonin reuptake inhibitors (SSRIs), make more neurotransmitters available by
blocking the reabsorption of neurotransmitters to alleviate depressive symptoms [6]. However,
people using SSRIs can develop a tolerance to them over time and may not respond to other
medications [7]–[10]. Treatment-resistant depression (TRD) is classified as a failure to respond
to at least two trials of pharmaceutical drugs [11]. An estimated 50 – 60% of patients do not fully
respond to antidepressant drugs, and of those 10 – 30% suffers from TRD [11]–[13].
Alternatively, new studies have found a correlation between the inflammatory response and
TRD [7] [14]–[18]. As such, a promising method for treating major depressive disorder is to
block the inflammatory signaling pathway by modulating cytokine levels [7], [19], [20].
1.2. The Effect of Vagus Nerve Stimulation on Cytokines
Studies are now focusing on the role of pro-inflammatory and anti-inflammatory
cytokines in the inflammation response. Cytokines are a substance secreted by cells associated
with the inflammatory system that communicate with the brain through neural and humoral
pathways [21]. An increased expression of pro-inflammatory cytokines interleukin 6 (IL-6) and
tumor necrosis factor (TNF-α) have been linked to patients with major depressive disorder and
found in post-mortem brain samples of suicide victims [4], [7], [22]–[25]. Inflammation begins
with the autonomic system, controlling key immune organs, such as the spleen, adrenal glands,
and bone marrow [26]–[28]. The spleen is made up of mostly red pulp that filters and recycles
blood components. There is also a small region of white pulp associated with the immune system
that generates antigen-specific antibodies and produces and stores lymphocytes [29]. The
inflammation response can be triggered by the presence of endotoxins. Endotoxins, also called
lipopolysaccharides (LPS), are components of the outer membrane of Gram-negative
bacteria [30]. LPS will react with LPS-sensitive cells mediating endotoxemia [26], [30], [31].
The resulting monocyte and macrophage production of TNF-α and other cytokines in the spleen
can be blocked by stimulating the vagus nerve [31], [32]. The vagus nerve is composed of 20%
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efferent and 80% afferent fibers and is often called the “wandering” nerve because of its vast
distribution throughout the body as it travels from the brainstem to the abdomen. Vagus nerve
stimulation (VNS) involves applying a mechanical or electrical signal to the nerve. Through the
vagus nerve, indirect connections can be made to autonomic functions as well as brain regions
associated with neuropsychiatric disorders [7]. Disease severity associated with inflammatory
syndromes can be reduced through VNS and the subsequent regulation of cytokine
production [21], [31]–[36].
In 1997 the U.S. FDA approved an implantable electrical VNS device for the treatment of
refractory epilepsy [37]. A cuff is secured around the vagus nerve through which these implanted
devices are able deliver electrical stimulation. Interestingly, there has been a reported decrease in
depressive symptoms, even when epilepsy symptoms have not improved [37]. This phenomenon
has been further explored in animal models specific to depression [37]. However, potential side
effects of this therapy are voice alteration, cough, dyspnea, dysphagia, and neck pain or
paresthesia. Also, efferent fiber damage due to cuffing was indicated by a decrease in Fluorogold
transport in the rat model for chronic VNS studies [38]. Cuffing the nerve is an invasive and
potentially damaging method. A solution to stimulate the nerve without cuffing it is focused
ultrasound (FUS).
1.3. Focused Ultrasound Overview
1.3.1. Piezoceramic Characteristics
The noninvasive aspect of the sound waves produced by FUS technology has a wide
range of medical and industrial applications. Ultrasound is classified as sound waves with a
frequency above the human hearing limit of 20 kHz. Ultrasound is produced by a piezoelectric
material when it is under some form of strain, such as mechanical or electrical. Inside the crystal
structure of this material the ionic charge distribution is symmetric, but when external stress is
applied there is a displacement of ionic charges and an overall net polarization [39]. If a voltage
is the external stress, the material will resonate and convert electricity to sound waves [40]. In
the 1940s research and commercialization of this piezoceramic material took off due to the
discovery of barium titanate and lead zirconate titanate (PZT) [39]. The applications for this
material expanded because of their increased dielectric and piezoelectric properties, and the
introduction of dopants to further modify the piezoelectric properties. The fabrication process for
PZTs begins with the powder preparation of lead oxide, titanium oxide, and zirconium oxide as
the main components. This is followed by calcining, sintering, and machining. The final steps
involve applying electrodes using a DC field to polarize the material giving it its piezoelectric
qualities [39]. Today PZTs are the most popular type of piezoelectric material and are available
in a variety of shapes with specific application-based properties.

3
1.3.2. Beam Formation Methods
FUS devices take advantage of the PZTs by inducing and directing sound waves to a
specific location. The beam is made up of the Fresnel Zone (near field), Fraunhofer Zone (far
field), and the focal point or region as seen in Figure 1 [41], [42]. Near-field diffraction occurs at
a finite distance from the transducer and the scattered waves will influence the shape and size of
the focal region. Far-field diffraction is not dependent on the distance between it and the
transducer and the scattered waves begin to turn into planar waves [43],[44]. The benefit of this
transducer technology is that the desired effect occurs in the focal region. Focusing of the beam
can be achieved with a curved PZT element, a phased array, a lens, or by electronic
method [40], [45]–[47]. Monolithic shapes such as hemispheres and spherical caps are a simple
choice to generating a stable focused beam [48]. A phased array incorporates multiple PZT
elements that can be geometrically and/or electronically focused. To electronically focus a
phased array, time delays are applied to create strategic constructive and destructive waves to
control the location of the focal region [49]. Each design has tradeoffs based on size, availability,
and cost.

Figure 1: Shape of FUS beam

1.3.3. Matching and Backing Layers
To protect and enhance the design of a FUS device, a front and back layer can be applied
to the PZT elements. The front layer is often referred to as a matching layer because, based on
the thickness and properties of that matching layer material, the acoustic performance can be
improved. To ensure maximum power transfer to the focal region studies have reported a
quarter-wave thickness and the need for a specific impedance for the matching layer [49]–[52].
The impedance of the matching layer needs to be the square root of the product of the acoustic
impedance of the transducer (Z1) and the acoustic impedance of the medium (Z2) the ultrasound
will be traveling into [50],[53].
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𝑀𝑎𝑡𝑐ℎ𝑖𝑛𝑔 𝐿𝑎𝑦𝑒𝑟 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 =

𝜆
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𝑀𝑎𝑡𝑐ℎ𝑖𝑛𝑔 𝐿𝑎𝑦𝑒𝑟 𝐼𝑚𝑝𝑒𝑑𝑎𝑛𝑐𝑒 = √𝑍1 ∗ 𝑍2

(1)
(2)

In a phased array, cross-talk between elements can result in unwanted ringing leading to a
reduction in acoustic power efficiency [49], [54]. Cross-talk is especially an issue in the case of
phase shifting because the ability to control beamforming is compromised. It is important to
maintain mechanical isolation between elements to avoid unwanted ringing. Options for fillings
between elements are a variety of epoxy or silicone materials [52], [54]. The backing layer also
plays an important role in acoustic performance. To avoid backward propagating waves from the
back face of a PZT element, a silicone substrate can be applied as a backing layer to attenuate
unwanted acoustic reverberations [49], [50], [52], [55]. Choosing a backing material with a high
acoustic impedance will extend the waveform duration resulting in the absorption of unwanted
signals, increased sensitivity, and increased signal amplitude [42], [50], [52], [55], [56]. It is also
important to note that the addition of silicone and epoxy to a mechanically sensitive material will
introduce capacitance into the system. The combination of the PZT elements, backing layer, and
matching layer are referred to as the transducer.
1.3.4. Impedance Matching
To achieve maximum power transfer efficiency, the impedance of each element in the
transducer needs to be matched to the source. If the source and transducer have mismatched
impedances, then there will be a drastic decrease in the overall performance of the
transducer [57]. A common impedance for matching in electronics is the standard transmission
line impedance of 50 Ω < 0⁰ [51]. Most PZTs will have a resonance frequency in a narrow
bandwidth where the amplitude of the sound waves will be the largest [58]. It is in this frequency
range that impedance measurements must first be taken. Subsequently, these measurements are
used to develop a network of reactive components for matching the transducer and the source.
Reactive components are inductors (L) and capacitors (C). The IEEE Standard on
Piezoelectricity recommends employing Van Dyke’s Model as the equivalent circuit of a
PZT [39], [57], [59] Using the measured impedance values the mechanical behavior and
electrostatic capacitance can be represented with a series RLC and parallel C in Figure 2a. The
dielectric loss is negligible and not shown in the model [57]. Ls and Cs represent the resonance
performance of the transducer. Rs is defined as the radiation and mechanical losses and C o as the
equivalent capacitance. However, if the mechanical losses are assumed to be relatively small, Rs
can then represent the acoustic power emitted and be simplified to be in parallel or in series with
Co [57], [60]. Above the resonance frequency, specifically between the resonance frequency and
the anti-resonance frequency, the equivalent circuit of the PZT is inductive. Below the resonance
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frequency region, the equivalent circuit of the PZT is capacitive [39]. A simplified model of the
equivalent circuit for a PZT element is shown in Figure 2b.

(a)

(b)
Figure 2: (a) Van Dyke’s Model at Resonance (b) Equivalent Circuit Representation of a PZT

Parameters to consider when designing a matching network are the cost of components,
size of components, and availability of specific values. When the frequency range is narrow and
the number of components needs to be conservative, a combination of inductors and capacitors
can be chosen to create a simple matching network [51], [57]. These reactive components will
compensate for any capacitive effects within the transducer by matching the imaginary and real
part of the complex conjugate of the transducer to the source [57]. Depending on which
component is in series or in parallel with the transducer, the configuration can also act as a low
or high pass filter. Both are acceptable designs, but the benefit of a low pass filter is that
potential harmonics from the driving source will not affect the transducer [57]. Without a
matching network the power transfer efficiency will be lost [58].
To evaluate the matching network, the standing wave ratio (SWR) and reflection
coefficient (Γ) need to be calculated for. Standing waves are the result of a mismatch in
impedance values between the load and the source. The result is that power is not efficiently
delivered to the load and is instead lost when it is reflected back toward the source. A Γ of 0 and
an SWR of 1 represents no reflection occurring in the system. To further characterize the effect
of impedance mismatching the power reflected and delivered can be calculated for using the
SWR and Γ [61][62].
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𝑆𝑊𝑅 =

𝛤=

𝑍𝐿
𝑍0

𝑆𝑊𝑅 − 1
𝑆𝑊𝑅 + 1

(3)

(4)

𝑅𝑒𝑡𝑢𝑟𝑛 𝐿𝑜𝑠𝑠 (𝑑𝐵) = −20 ∗ log10(|𝛤|)

(5)

𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑖𝑜𝑛 𝐿𝑜𝑠𝑠 (𝑑𝐵) = −10 ∗ log10 (1 − 𝛤 2 )

(6)

𝑃𝑜𝑤𝑒𝑟 𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑒𝑑 (%) = |𝛤|2 ∗ 100

(7)

𝑃𝑜𝑤𝑒𝑟 𝐷𝑒𝑙𝑖𝑣𝑒𝑟𝑒𝑑 (%) = (1 − |𝛤|2 ) ∗ 100

(8)

1.3.5. Signal Amplification
Another electrical block that needs careful design considerations within a FUS device is
the amplification of the signal. The amplifier or network of amplifiers will receive a signal,
amplify it, and pass it along to the matching network onto the transducer to create ultrasound. To
avoid wasting energy in the form of heat dissipation, the amplifier needs to operate at a high
efficiency. This is especially true when dealing with phased arrays where each PZT element will
have its own matching and amplifying network. If the amplification network fails, depending on
the type of amplifier, there is a risk of uncontrolled electrical power being applied to the
transducer. Too much power can result in losing control of the ultrasound beam as well as
damaging the PZT elements [63]. Damage to the PZT elements, such as overheating, could
change their impedance [39], [63], [64]. A change in impedance will compromise the tuned
matching network, which will result in inefficient power transfer.
Considerations for amplifier choice are power consumption, cost, size, and external
components. When designing an amplification network, there are a variety of amplifiers to
choose from such as power, operational, voltage, or current amplifiers. Power amplifiers have
their input and output internally matched at 50 ohms, which is useful when operating between a
50 ohm source and a 50 ohm matched network for the transducer. Operational amplifiers have
low efficiency and will consume power even in the absence of a signal. Voltage and current
amplifiers are characterized by a mismatched input and output impedance of high or low to
maximize voltage or current transfer [63]. Most of these will have a recommended application
circuit for incorporating the part into the circuit design. The circuits consist of reactive
components based on desired frequency range and impedance. These external networks are
important to investigate before purchasing an amplifier when space conservation is a priority.
Another option is to purchase an industrial sized amplifier that will have a controllable power
output and guaranteed circuit protection guards. There are also amplifiers available for phased
arrays that have two to sixty-one channels to independently drive each PZT element (E&I).

7
However, this option is not always feasible because these types of amplifiers can cost thousands
of dollars.
1.4. Calculating Intensity
Evaluating the efficacy of a FUS device can be done with a hydrophone. A hydrophone is
an instrument that contains a small PZT element that is sensitive to variations in pressure
amplitude and will produce a proportional voltage. The PZT element is housed in a protective
casing and is coupled to external conductors [65]. The hydrophone casing can be made of
polyvinylidene difluoride (PVDF) which is a flexible and heat resistant material that is
commonly used as electrical insulation. As the hydrophone records the pressure changes based
on location from the transducer, the signal will pass through a voltage preamplifier. This is used
to filter and/or add gain to the signal before it is displayed on an oscilloscope. Measurements are
best taken in degassed and distilled water inside an anechoic like container that will not allow
sound waves to reverberate off the walls and compromise the recorded values. This is a common
method of characterization of the acoustic field for FUS devices. The recorded voltage amplitude
and acoustic impedance of the medium can be used to calculate the acoustic instantaneous
intensity (I), the rate at which sound energy flows through a unit area [40]. In the field of medical
ultrasound, intensity is represented using W/cm2 [66]. When the signal is pulsed, the type of
intensity being reported can be specified (Equations 9 – 13). The acoustic intensity can further be
defined as the spatial peak temporal average intensity (ISPTA) and as the spatial peak pulse
average intensity (ISPPA). ISPTA is the average intensity of a pulse repetition period and ISPPA is the
average intensity of a beam over a pulse duration [43], [65].

𝑃=

𝑉𝑝𝑝
(𝑔𝑎𝑖𝑛)
𝑂𝑉𝐶

𝑃𝑟𝑚𝑠 =
𝐼=

(9)

𝑃

(10)

2√2

2
𝑃𝑟𝑚𝑠
𝑍

(11)

𝐼𝑆𝑃𝑇𝐴 = 𝐼 ∗ 𝐷𝐶

(12)

𝐼𝑆𝑃𝑃𝐴 = 𝐼𝑆𝑃𝑇𝐴 ∗ 𝑃𝑅𝑃

(13)

Where Vpp is the recorded amplitude from the oscilloscope, P is the pressure
amplitude (Pa), gain is set on the voltage preamplifier (dB), OVC is the hydrophone sensitivity
(V/Pa), P is the pressure amplitude (Pa), Z is the acoustic impedance of the medium (kg/ms 2),
DC is the duty cycle (ms), and PRP is the pulse repetition period (s) [43], [65], [67].
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1.5. High Intensity Focused Ultrasound
FUS devices can fall into the low intensity focused ultrasound (LIFU) or the high
intensity focused ultrasound (HIFU) category. HIFU uses intensities of up to 100 W/cm2 and is
used for more extreme types of therapy such as, ablation, cavitation, and penetrating the blood
brain barrier [68],[69]. The first FUS device to be FDA cleared was the Sonablate for ablation of
prostate tissue in 2015. This device is used to non-invasively target compromised tissue and heat
it up to 100⁰C with bursts of energy that cause thermal tissue coagulation, necrosis, cavitation,
and heat shock [70]–[72]. The challenge associated with this type of technology is delivering
therapy to the focal region without damaging the surrounding tissues [45]. The risk of unwanted
energy absorption to the surrounding tissue is an issue for HIFU because ultrasound will
attenuate faster at higher frequencies than at lower frequencies [41], [42]. With strides made in
medical imaging technology, HIFU has become more clinically relevant because the therapy can
be accurately positioned and the progress of tissue destruction monitored [70]. This type of
therapy requires a substantial amount of power and precision. As PZT elements get smaller and
more numerous in a phased array, the beam steering capability improves. It is common for HIFU
devices to have anywhere from 16 to 256 elements [42], [73]–[78]. The tradeoff is that each of
the active elements will need their own network for matching, amplification, and phase shifting.
The typical input electrical power to each active element can range from
0.5 W to 6 W [51], [74], [75], [77]–[79]. Further, the PZT elements and electrical components
will need to be of high quality to handle the power necessary for HIFU applications. All of these
considerations quickly drive up the cost, size, and power consumption for these devices.
1.6. Low Intensity Focused Ultrasound
LIFU is often used for neuromodulation through mechanical stimulation. LIFU is
commonly used in studies that focus on neurological or psychiatric disorders due to its ability to
both excite and suppress neuronal activity [68], [80]–[85]. LIFU devices tend to employ concave
shaped PZT elements and deliver a pulsed stimulation with an ISPTA of up to 10 W/cm2 [86].
Specifically, for neuromodulation studies an ISPTA of less than 500 mW/cm2 is used [68],
[87],[88]. These lower intensity values are within compliance of the FDA limit for diagnostic
imaging at an ISPTA less than 700 mW/cm2 [89],[90]. There are a number of studies that
investigate the therapeutic effect of applying neuromodulation using intensities values in the
mW/cm2 range, however the parameters will vary greatly between studies [68], [87], [89]–[93].
The result of the LIFU therapy can also vary between excitatory or inhibitory based on the
stimulation parameters. The benefit of the reversible biological effect of LIFU is that it can be
used for modulation in a region of interest multiple times over an extended period of time
without permanent tissue damage [68], [94]. The bimodal advantage of LIFU also yields
challenges. A specific intensity may yield a wanted suppressive effect. However, just below or
above that target intensity there will be a report of no effect or an excitatory effect, respectively
[90], [95]. LIFU requires more fine tuning of parameters to achieve the desired neuromodulation
outcome than HIFU, but the research is promising and worth continued exploration.
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1.7. Study Overview
The Center for Implantable Devices (CID) at Purdue University is combining its
expertise in biomedical and electrical engineering to look into the pathophysiology of the
inflammatory response that has been linked to depression. The two forms of VNS therapy that
CID is researching are electrical and LIFU. Through a collaboration formed between Dr. Pedro
Irazoqui’s CID lab and Dr. Eduardo J. Juan García’s lab at the University of Puerto Rico Mayagüez, resources were made available to create a team to look exclusively into LIFU. Using
the H-115 Sonic Concepts FUS system loaned from Dr. Juan García’s lab, my colleague, Kelsey
Wasilczuk and I conducted research to investigate the merit of LIFU for the modulation of
cytokines, specifically TNF-α. As this project continues to collect data on LIFU in VNS, I
shifted my focus to building a device based on issues that arose in our research. As we began to
look into purchasing our own device and accessory equipment for the CID lab we were unable to
identify a system that was affordable. Many FUS transducers and the required backend
electronics are expensive, large, and cumbersome. I address this issue by combining affordable
off the shelf components. I will go into detail on the design decisions and construction of my
transducer and circuit board consisting of matching and amplification networks. I then worked
with Wasilczuk to conduct animal studies using my LIFU device. My research goal was to
design a small, affordable LIFU device that could be used for cytokine modulation to relieve
depressive symptoms.
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2. METHODS

2.1. Transducer Design
2.1.1. Earlier Prototypes
I constructed two prototypes before the final LIFU device. With each prototype of the
device I was able to fine-tune the fabrication process and the electrical circuitry. A description of
the prototyping process and how I arrived at my final design can be found in the discussion
section. The results associated with these prototypes can be found in the supplementary section.
2.1.2. PZT Selection
After correspondences with multiple PZT manufactures about price and availability of a
single concave PZT element, I chose to instead build a phased array device because the materials
would be more affordable. I purchased piezoceramic discs from STEMiNC. The dimensions of
the PZTs were 5.0 mm diameter x 0.4 mm thickness with a resonance frequency of 450 kHz.
These PZTs are a material called SM111, which is a modified form of PZT-4. Comparisons of
material properties provided by the company are shown in Table 1. To avoid damaging the PZTs
with heat, wires were attached to the positive and negative electrode of the PZTs by the
company. I used a free cross-platform ultrasound simulation toolbox to write a code that
calculated the radius of curvature and number of PZT elements to incorporate in my phased array
based on the desired focal point (FOCUS). The results are displayed in Figure 3.
Table 1: PZT Material Properties Comparison
Property

Unit

0.54

0.58

Kt

0.43

0.45

K31

0.32

0.34

x10m/v

d33

300

320

d31

-130

-140

x103
Vm/N

g33

26.4

25

g31

-12.9

-11

@1kHz

ε (F/m)

1300

1400

12

Dielectric
Constant

Modified PZT-4

Kp

Electromechanical
Coupling
Coefficient

Piezoelectric
Constant

Symbol PZT-4
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(a)

(b)

(c)
Figure 3: FOCUS generated simulations. (a) Geometry for phased array. (b) Normalized intensity field
based on phased array geometry. (c) Normalized intensity along the z axis to simulate the location of the
focal region from the center of the transducer. The depth of the transducer was modeled to be 4 mm.
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2.1.3. Transducer Geometry
Based on the location of the vagus nerve from the surface of the skin in rats, the focal
point was selected to be approximately 10 mm. This value was collected during Wasilczuk’s
animal studies from her surgical assistants. I ran simulations and recorded measurements with
0 mm representing the center of the transducer. The final distance from the center of the
transducer to the end of the transducer was 4 mm, so the focal region was represented in
simulations as 14 mm. With help from Kevin Buno, a graduate student in the biomedical
engineering department, I designed the shape of the transducer in SolidWorks and 3D printed the
component on campus using an Ember 3D Printer (AutoDesk). All prints were done with 1x1L
standard clear prototyping resin, XY resolution of 50 microns, and Z resolution of 10 microns.
To account for the porous qualities of the 3D printed concave disc I treated the component with
acetone. Figure 4 shows the design of the concave disc with nine inserts for the PZTs to be
secured into with epoxy and silicone. Table 2 is a list of the final transducer design decisions.
Table 2: LIFU Transducer Dimensions
PZT Material
PZT Diameter x Thickness
Resonance Frequency
Number of PZTs
Focal point from end of transducer
Outer Diameter
Inner Diameter
Radius of Curvature

Modified PZT-4
0.5 mm x 0.4 mm
450 kHz
9
10 - 12 mm
22 mm
20 mm
14.5 mm

Figure 4: SolidWorks design of transducer geometry. Scale bar = 5 mm.

2.1.4. Backing and Matching Layer
For the backing and matching layers, I chose medical grade silicone (NuSil MED2-4420)
and medical grade epoxy (Loctite® M-31CLTM Hysol®), respectively, based on literature and
availability. Wearing nitrile gloves, I carefully placed three PZTs at a time into their slots and
applied the silicone backing to hold them in place. The silicone cure time was three minutes and
did not require any heat that would compromise the PZT characteristics. Identified by literature,
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the optimal matching layer of λ/4 meant that I needed to apply an even layer of 0.88 mm onto the
concave disc. I rounded down to 0.8 mm to allow for 0.08 mm of tolerance. To achieve this even
layer, I first modified my SolidWorks design of the concave disc by removing all of the PZT
slots. I then added a 0.8 mm thickness to the design and 3D printed it. Using this component, I
next used mold putty, which epoxy would not adhere to, to create the negative mold to form an
even layer of epoxy onto the face of my transducer. A schematic of the matching layer procedure
is represented in Figure 5. The “Amazing Mold Putty” is FDA-compliant 1:1 ratio silicone mold
putty that was hand mixed and cured in 20 seconds (Alumilite). I put epoxy into the concave disc
with the exposed PZT elements and then pressed the negative mold on top. This fixture of the
concave disc and positioned negative mold was left overnight because the epoxy has an 18-hour
cure time at room temperature. When the mold was removed, a 0.8 mm cured layer of epoxy was
present. This was verified by grinding down the 3D printed test concave shape as seen in
Figure 6.

Figure 5: Setup for applying a specific matching layer thickness to transducer

Figure 6: Cross-sectional view demonstrating even application of matching layer

2.1.5. Matching Network
The driving force behind the development of the matching network calculations and
associated MATLAB code was Christian J Colon Ortiz from Dr. Juan García’s lab. We selected
a matching L network to deliver maximum power to the load from the source with an impedance
of 50 ohms (Z0). Referencing Figure 7, there are two different circuit layouts based on how the
load impedance compares to the source impedance. There are eight potential combinations of
capacitors and inductors for this type of matching network. To narrow down the selection, I
measured the Z (ZPZT) and theta (ϴPZT) values of each PZT with an E4980A Precision LCR
Meter (Agilent) at 450 kHz. Specifically, the impedance of the PZTs set in the concave disc with
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the backing and matching layer applied were used in the calculations. I assigned each PZT an ID
to keep track of the impedance and matching network values associated with it. Based on a
simplified Van Dyke’s Model and recorded measurements, we modeled the PZTs as a resistor
and capacitor in series.

(a)

(b)

Figure 7: Matching L Networks for eight potential combinations of inductors and capacitors. (a) Network
used when impedance of transducer is less than impedance of source. (b) Network used when impedance
of transducer is greater than impedance of source.

The calculated PZT impedances were greater than the 50 ohm source impedance. As
such, this narrowed the potential matching network layouts to those having the transducer in
series with the first reactive component then in parallel with the next reactive component. The
remaining four combinations were made up of inductors and capacitors (Table 3). Case 1 and
Case 2 were the chosen layouts.
Table 3: Potential combinations of inductors and capacitors for matching L network
Combinations Series Xm Component Shunt Bm Component
Case 1
XL
BC
Case 2
XC
BL
Case 3
XC
BC
Case 4
XL
BL

Between the last two combinations of capacitor or inductor for the shunt (Bm) or series
(Xm) value, the network was chosen based on availability of reactive components’ values on
Digi-Key. Equations 14 – 17 show how the series and shunt components were calculated for. A
more in-depth break down of the matching network calculations has been covered by other
researchers [39],[57],[96].
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𝑅𝑡 = 𝑍𝑃𝑍𝑇 ∗ cos(𝜃𝑃𝑍𝑇 )

(14)

𝑋𝑡 = 𝑍𝑃𝑍𝑇 ∗ sin(𝜃𝑃𝑍𝑇 )

(15)

𝑅𝑡
√𝑅𝑡2 + 𝑋𝑡2 − 𝑍0 ∗ 𝑅𝑡
𝑍0 ∗
𝐵𝑚 = 𝑋𝑡 ±
𝑅𝑡2 + 𝑋𝑡2

(16)

√

𝑋𝑚 =

1
𝑋𝑡 ∗ 𝑍0
𝑍0
+
−
𝐵𝑚
𝑅𝑡
𝐵𝑚 ∗ 𝑅𝑡

(17)

Colon Ortiz wrote a MATLAB code to calculate the impedance and graphical
representation of the resonance frequency that each of the two combinations would give based on
readily available values. The overall efficiency of each matching network was calculated for
using Equations 3 – 8.
2.1.6. Power Amplifier
The radio frequency (RF) power amplifier I chose was based on size, price, and
availability. I ordered this 4.5 mm x 4.15 mm x 1.50 mm amplifier off of Digi-Key for $1.88.
The frequency range and number of components needed for the external network narrowed the
search down. The MMG3H21NT1 from NXP is internally matched at 50 ohms, can be used at
450 kHz, needs a single 5 volt supply, and has a small signal gain of 19.3 dB. The application
circuit values were provided by the company, listed in Table 4, after I contacted them and told
them what frequency range (450 kHz) I was operating in (Figure 8).

Figure 8: 50 Ohm Application Circuit Schematic for 450 kHz
Table 4: 50 Ohm Application Circuit Values for 450 kHz
Part
C1, C2, C4
C3
L1
R1

Description
1 µF
0.1 µF
33 µH
0Ω
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2.1.7. PCB Design
I used an open source EDA software to create my PCB circuit schematics and layouts
(KiCad EDA). CID has a LPKF ProtoMat®S100 circuit board plotter for in-house rapid PCB
prototyping that I used (LPKF). I fabricated PCB boards containing matching networks for each
PZT on one side and the amplifiers with their external networks on the other side. To help with
heat dissipation, I designed and implemented a large, shared ground plane between the amplifiers
and placed a heat sink over the amplifiers with adhesive tape. I soldered on the surface-mount
device (SMD) components and pin outs under a microscope with Chip Quik® lead free low
temperature solder paste (SMDLTLFP10T5) and a hot-air rework station 303D (Sparkfun) set at
220⁰C. The pin outs were for power, input signal, and ground. The positive and negative wires of
each PZT were soldered to their specific matching network and amplification channel.
2.2. Bench Top Characterization
A E3630A triple output DC power supply (Agilent) was set at 5 volts and 12 volts to
respectively power the device and the TC4038 hydrophone (Teledyne Reson) VP1000 voltage
preamplifier (Reson). The voltage preamplifier was set to a 50 kHz high pass filter with a 32 dB
gain. The 33522A function waveform generator (Agilent) supplies a 450 kHz sine wave with
varying amplitudes. The transducer was submerged in deionized water in a rubber lined
container (Figure 9). When the input signal and power source were turned on, the amplitude
recorded from the hydrophone was displayed on the MS0734B mixed signal oscilloscope
(Agilent). I measured pressure at various locations and amplitudes. I created a 8 mm x 20 mm
2D intensity map of the FUS beam starting from the edge of the transducer and evaluating the x
and z axis. I measured in 2 mm increments to 20 mm in the z direction. I measured in 2 mm
increments from -4 mm to 4 mm in the x direction. The 0 mm point represents the middle of the
transducer.
When the intensity map was created the focal region was further characterized. The focal
region evaluated was a 2 mm x 4 mm region at 10 mm to 12 mm from the center of the
transducer. I created intensity maps of the focal region and varied the amplitude from -6 dBm to
9 dBm. I selected the amplitude parameter of -3 dBm based on the shape and location of the
focal region. The type of intensity reported was instantaneous intensity. To evaluate the potential
of beam steering for future iterations, I disconnected three of the PZTs and created a
10 mm x 20 mm intensity map of the shifted FUS beam.
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Figure 9: Bench top test setup for measuring the amplitude of the soundwaves with a hydrophone. The
hydrophone was secured in place and the LIFU device was moved in the x and z axis using a stereotactic
frame.

2.3. Surgical Overview
2.3.1. Surgical Setup
To measure the effect of the LIFU therapy on the modulation of cytokines, in vivo rat
experiments were performed with the assistance of Wasilczuk and Albors as the surgeons. We
used 12 male 200 - 300 gram Sprague-Dawley rats. All surgical procedures were approved by
the Purdue Animal Care and Use Committee (PACUC). The rats were first anesthetized with
4 – 5% isoflurane so that we can weigh and shave the rats in the regions of surgical interest. At
the beginning of each surgery, we gave the rats an intraperitoneal (IP) injection of 0.04 mL
butorphanol. I immediately administered an induction IP injection of ketamine-xylazine
(ket/xyl), a mixture of 75 mg/kg ketamine and 5 mg/kg xylazine. Throughout the experiment, the
rats were placed on a heated surgical mat and supplied with oxygen at 2 L/min. Every
20 minutes, we gave a maintenance IP injection of ket/xyl.
2.3.2. Pre-Made LPS Procedure
To induce endotoxemia, we IP injected an LPS-saline mixture (5 mg/kg). LPS arrived in
a 100 mg glass bottle from Sigma Aldrich. Jennifer Sturgis from Robinson’s lab helped us
prepare pre-made LPS for the animal study. We first mixed 15 mL of saline into the glass bottle
containing the 100 mg of LPS. We transferred this amount to a polypropylene tube. We injected
another 5 mL of saline into the glass bottle. The glass bottle and polypropylene tube were
sonicated for 30 minutes. We transferred the remaining 5 mL of saline to the polypropylene tube
to be sonicated for another 15 minutes. We aliquoted 0.4 mL of the LPS saline solution into
Eppendorf tubes that were then placed in a frost free freezer. Before each surgery we weighed
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each rat and calculated the amount of LPS needed. Based on the result we pulled out the number
of prepared tubes before the experiment. We sonicated the tube for 30 minutes and then pulled
the specific amount needed for injection. This process ensures that the dosage was consistent for
each surgery.
2.3.3. Surgical Timeline
To ensure that the left cervical vagus was receiving the full stimulation, the surgeons
exposed it with a 20 mm incision on the neck of the rats. They also exposed and inserted a
catheter into the left leg of the rat for blood collections, which occured in 30 minute intervals. To
avoid the formation of blood clots in the line, we flushed the catheter with heparinized saline
every 15 minutes. We took the first blood collection following the exposure of the vagus and
catheter insertion. This collection represented the baseline sample and is denoted as time point
“-30 minutes”. Thirty minutes later represents time point “0 minutes” and was when I injected
the LPS. No blood was taken at this time point. To minimize experimental variability, I
performed all of the LPS injections throughout the animal studies.
After the LPS injection, I setup the LIFU device for VNS. I applied ultrasound gel
(Aquasoinc 100) to the incision site, which provided a medium for the ultrasound waves to travel
through from the transducer to the vagus nerve (Figure 11). I carefully situated the transducer
head above the target and then pressed it up against the rat’s neck. The device was held in place
with alligator clips attached to a base by flexible arms. The power supply and function generator
were connected to the PCB board. I took the second blood collection at time point “30 minutes”
and then immediately turned the LIFU device on for a total of 5 minutes. In thirty minute
increments four more blood samples were taken to show the effect of stimulation on the cytokine
levels. A total of six blood samples were collected. A detailed timeline of the surgery can be
found in Figure 10. Immediately after collection, each sample was placed on a rocker until they
were picked up for flow cytometry analysis done on campus by Paul Robinson’s Flow
Cytometry Lab. At the end of the experiment, we euthanized the rat with 0.9 mL of beuthanasia.

Figure 10: Surgical Timeline
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Figure 11: Surgical setup of rat with LIFU device positioned over the vagus nerve and a left leg catheter
for blood collection.

2.3.4. Flow Cytometry
We collected the blood in 300 µL K2 ETDA coated vials. After Robinson’s lab received
the vials, they centrifuged the samples and removed the plasma. They performed a
LEGENDplexTM Rat Inflammation Panel assay using fluorescent beads coated with antibodies
for specific analytes. The cytokines of interest are IL-6, IL-10, and TNF-α. The concentration of
each specific cytokine was found through measuring the analytes present with flow cytometry.
Two replicates and an average of the concentration are reported for each time point.
2.3.5. Surgical Considerations
The control rats used for this study received LPS, but no therapy. I used control data from
Wasilczuk’s animal studies because our experimental procedures only differ in the type of
therapy applied. I compared the effect of my LIFU device therapy against the control data.
I filled out surgical logs detailing the events of each animal surgery. Based on issues that
involved LPS injections or breathing the data was removed from the study. Breathing issues
included rats that did not handle the ket/xyl well and as a result, had elevated heart rates
throughout the experiment or stopped breathing and had to be revived.
2.4. Statistical Analysis
I consulted with Wasilczuk and Ahmad Hakeem Abdul Wahab, from the Purdue
University Statistical Department, on the statistical analysis of my results. Rats that received
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therapy from the LIFU device are designated with the FUS label. We plotted the average TNF-α
concentration of the controls against the average of the FUS rats for each time point. We next
conducted a Cohen’s h analysis to determine the peak concentration of TNF-α. We observed a
peak concentration at time point “90 minutes” and identified this as the point of analysis. At that
time point the TNF-α concentration of each FUS rat was plotted alongside the average control
TNF-α concentration data. To identify which rats did not respond to the therapy we used the
statistical package SAS 94 to calculate the studentized residuals. Finally, we performed a twosample t-test, with an α = 0.05, between the controls and the rats that responded to the therapy. If
the P value was less than 0.05, the results were considered statistically significant.
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3. RESULTS

3.1. Geometric Comparison
The images and dimensions of the final LIFU device design are presented in Figure 12.
The final design consisted of a transducer, matching network, and amplification network. With
the heat sink and transducer the device is 50 mm x 57 x 76 mm.

(a)

(b)

(c)
Figure 12: (a) Final LIFU Device Design. (b) Amplification network with heatsink over nine amplifiers.
(c) Final dimensions of 50 mm x 57 mm x 76 mm.
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A comparison between the H-115 system and the LIFU device is presented in Figure 13.
This image shows the transducer, coupling cone, matching network, and amplifier that make up
the H-115 system.

Figure 13: System comparison of H-115 and LIFU device: transducer, matching network, and
amplification network. The six inch ruler was included for reference.

3.2. Price Comparison
A price comparison between the H-115 system and the LIFU device are presented in
Table 5 and Table 6. The price breakdowns pertain to the transducers, matching networks, and
amplification networks. A further break down of the LIFU components is located in Table S4
and Table S5. The total cost of the H-115 system is $9,835 and the total cost of the LIFU device
ranges from $80 to $232.84. A range is provided for the LIFU device because the price is
dependent on material choice and availability.
Table 5: Bill of Materials for H-115 System
H-115 System
PZT Element
Matching Network
Coupling Cone
AE 7224 Amplifier
Grand Total ($)

Price ($)
$4,250.00
$685.00
$4,900.00
$9,835
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Table 6: Bill of Materials for LIFU Device
LIFU Device

Component
PZT Elements
*Silicone
*Epoxy
*Mixing Tips

Transducer

Matching Network

Amplification Network

*Mold Putty
Inductors
Capacitors
Amplifiers
Heatsink
Inductors
Capacitors

Vendor
STEMiNC
Nusil
Henkel
McMaster-Carr
Alumilite
Digi-Key
Digi-Key
Digi-Key
Digi-Key
Digi-Key
Digi-Key

Price ($)
29.00
100.50
20.00
11.40
20.00
6.79
10.00
18.76
5.66
5.47
5.26

*CID Resources
**Full price break down in Table S4 and Table S5.
232.84
80.94

Grand Total ($)
In-House Total ($)

3.3. Matching Network Development
The measured and calculated values for the nine PZTs are presented in Table 7. The
impedance values I recorded represent the values of the PZTs after they had been incorporated
into the transducer. I used the impedance values to calculate the potential values for the series
and shunt components (Table 8). The potential combinations of the values are presented in
Table 3. The final values I selected and their calculated power transfer efficiency are presented in
Table 9. A graphical representation of the power transfer efficiency and resonance frequency for
one of the PZTs is presented in Figure 14.
Table 7: PZT Impedance Characterization
PZT
ID
A1
A2
A3
B1
B2
B3
C1
C2
C3

Z (ohms)
910.40
887.70
863.70
890.40
775.70
713.70
967.20
842.40
911.50

Theta (degrees)
-51.70
-50.09
-45.08
-52.20
-47.76
-45.60
-52.90
-46.80
-48.04

Rt (ohms)
564.25
569.53
609.87
545.73
521.45
499.35
583.42
576.66
609.44

Ct (nF)
0.50
0.52
0.58
0.50
0.62
0.70
0.46
0.58
0.52
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Table 8: All potential inductor and capacitor values for series X m component and shunt Bm component
PZT
ID
A1
A2
A3
B1
B2
B3
C1
C2
C3

Series Xm
Shunt Bm
Component
Component
XL (µH) XC (nF) BL (µH) BC (nF)
94.2
1.33
78.8
0.98
91.3
1.37
76.9
1.01
85.7
1.46
74.0
1.11
93.7
1.34
78.0
0.98
83.1
1.51
70.4
1.10
77.9
1.61
66.5
1.17
98.6
1.27
82.2
0.94
85.9
1.46
73.5
1.09
90.6
1.38
77.3
1.04

Table 9: Final shunt inductor and series capacitor values for case 2 combination of series Xc and shunt
Bm components and the calculated power delivered.
PZT
XC (nF) BL (µH) Power Delivered (%)
ID
A1
1.3
82
99.734
A2
1.4
75
99.908
A3
1.4
75
99.961
B1
1.4
75
99.781
B2
1.5
68
99.914
B3
1.6
68
99.918
C1
1.3
82
100.000
C2
1.4
75
99.934
C3
1.4
75
99.895
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Figure 14: Graphical representation of ideal vs actual components selected for matching network

3.4. LIFU Device Characterization
I created a 2D plot of the intensity for the characterization of the LIFU device (Figure
15). The shape of the focal region was 1 mm x 4 mm and occurred between 10 mm and 12 mm
from the transducer. I disconnected three of the PZT channels and demonstrated a shift in the
focal region (Figure 16). The shape of the focal region was 1 mm x 1 mm and occurred between
10 mm and 14 mm from the transducer. The general focal region identified, when all of the PZT
channels were operating, was 4 mm x 2 mm at 10 mm to 12 mm from the transducer. I evaluated
the focal region further by varying the amplitude from -6 dBm to 9 dBm. Figure 17 shows the
progression of the focal region shape and location based on the amplitude variations.
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LIFU Device Amplitude Characterization
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Figure 15: 2D intensity map of the LIFU device at -3 dBm. The focal region was 1 mm x 4 mm and
occurred between 10 mm and 12 mm from the center of the transducer. The color bar represents the
intensity in W/cm2.

LIFU Device Characterization at -3 dBm
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Figure 16: 2D intensity map of the LIFU device at -3 dBm. The focal region was shifted 8 mm from the
center of the transducer. The focal region was 1 mm x 1 mm and occurred between 10 mm and 14 mm
from the center of the transducer. The color bar represents the intensity in W/cm2.
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(a)

(d)

(b)

(e)

(c)

(f)

Figure 17: A focal region of 4 mm x 2 mm was evaluated 10 mm to 12 mm from the center of the
transducer. At this position the amplitude was varied from – 6 dBm to 9 dBm. The focal region shape and
location varied based on the amplitude. The color bar represents the intensity in W/cm2.
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3.5. Animal Study
The animal study we conducted evaluated the concentration of TNF-α. We identified
time point “90 minutes” as the peak concentration of TNF-α in Figure 18 and this was further
confirmed with the Cohen’s h analysis (Figure 19 and Table 10). Cohen’s h proportional analysis
was used to identify where meaningful differences were between the controls and the FUS data.
Figure 20 represents the data recorded at time point “90 minutes.” The average for the controls
and the average for each FUS rat are presented in Figure 20. Each FUS data bar was the average
of two replicates received from the flow cytometry process.

TNF-α Average Concentration at Each Time Point

Concentration (pg/mL)

2500
2000
1500
Control Average

1000

FUS Average

500
0
-30
-500

0

30

60

90

120

150

Time (minutes)

Figure 18: TNF-α average concentration data for 8 rats that received therapy from the LIFU device and 5
rats that did not receive therapy. Based on events recorded in the surgical logs, 4 of the FUS rats were
removed from the study.
Table 10: A meaningful difference between the Cohen’s h proportions can be deemed small (greater than
0.2), medium (greater than 0.5) or large (greater than 0.8).
Time

Difference

-30

0.07

30

0.20

60

0.63

90

0.47

120

0.03

150

0.35
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TNF-α Cohen's h Analysis
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Figure 19: Cohen’s h proportional analysis of the three cytokines TNF-α, IL-6, and IL-10.

TNF-α Concentrations at Time Point 90
3000

Concentration (pg/mL)

2500
2000
1500
1000
500
0
Control FUSx002 FUSx005 FUSx006 FUSx008 FUSx009 FUSx011 FUSx013 FUSx014
Average
Figure 20: Evaluation of therapies at time point “90 minutes” for controls and the LIFU device. There
was an n = 5 for control data. Error bar for the control represents standard deviation. Each FUS label
represents one rat. There are no error bars for the FUS data because the data is represented as the average
of two replicates.
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4. DISCUSSION

4.1. LIFU Design Goal Overview
The goal was to design and fabricate a LIFU device based on the parameters of cost, size,
and consolidation of accessory electronics. A price range of a few hundred dollars was set. I
wanted to eliminate the need for expensive equipment, such as an amplifier. The goal was to
design a PCB circuit board that would contain a matching and amplification network for the
transducer. It was important to consider power consumption, but it was difficult to set a specific
parameter when LIFU device studies do not report it and HIFU device studies do not prioritize it.
LIFU device studies are more focused on the biological response of the therapy and will use
established FUS systems. HIFU studies that focus on the fabrication of the device will report
power consumption, but they are operating at such extreme intensities an industrialized amplifier
is typically chosen over building their own amplification network. However, I did reference
many HIFU studies for the fabrication of my device because they were highly detailed on their
design processes for the transducer and matching network.
Design considerations were based on issues that arose when Wasliczuk and I used the H115 system in animal studies. The experiments were performed on 200 – 300 gram SpragueDawley rats. The transducer diameter needed to be less than the size of the rat’s neck. When
pressed up against the neck of a rat the focal region of the beam needed to occur at
approximately a 10 mm depth, where the vagus nerve is located. This design specification arose
from issues with maneuverability of the H-115 transducer. The diameter of the PZT element is
64 mm with a focal length of 40 mm. The focal length is where the focal region occurs with
respect to the face of the PZT element. With such a large device it is difficult to aim for a rat’s
nerve, but with the coupling cone the user only needs to measure a distance of 10 mm from the
end of the cone to the target. The coupling cone is attached to the PZT element, filled with water,
and has an opening where a cover, secured with an O-ring, is placed over. Ultrasound gel is then
placed between the end of the cone and the target. The water and gel provide a bridge for the
ultrasound to travel through. Due to the extreme focal length, the H-115 system needs to be
mounted and precisely placed, using a stereotactic frame, before stimulation (Figure 21). It was
important to build a device with a transducer head that that would press directly against the skin
without the use of a coupling cone. In Wasilczuk’s animal studies the H-115 system operates at
250 kHz and targets the vagus nerve with an ISPTA of 2.3 W/cm2. My device needed to produce a
FUS shaped beam with an intensity that could induce a therapeutic effect in the animal study.
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Figure 21: H-115 Transducer with coupling cone mounted and positioned over the vagus.

4.2. PZT Shape Considerations
Many LIFU studies focus on the biological response of their therapy as well as how the
device affects tissues surrounding the focal region [89], [97]–[99]. These studies often employ
the use of a single-element PZT, a function generator, and an amplifier. The single-element is
typically curved and purchased from a manufacturer. I first reached out to Sonic Concepts, the
manufacturer of the LIFU device we had on loan. They had many therapeutic transducers
available in a variety of sizes and frequencies. However, the price quotes were for thousands of
dollars and the accessories, such as the coupling cone, were well above my target
budget (Figure 22).

Figure 22: H-115 Transducer, Coupling Cone, and Matching Network
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Since these transducer systems came with the matching network, I decided to contact
multiple PZT manufacturers about purchasing just a curved PZT element that was capable of
operating at a low frequency, had a small diameter, and had a focal point of about 10 mm. After
consulting with the sellers, I learned that my design requirements (specifically a small diameter,
curved PZT element) would require a customized PZT element, which was quoted at $300 to
$500 for each element with a minimum purchase order of ten. My next attempt was to purchase a
pre-made curved PZT element or get a free sample of a curved PZT element from a vendor, but I
did not receive a response or was unable to find a reasonably priced element. Souris et al used a
CNC machine with a grinding spindle, equipped with diamond tools, to shape a piece of bulk
PZT element into their desired curved shape. However, the inner and outer surfaces needed to be
silvered to create electrodes for polarizing the element. During this silvering process, a high
voltage is applied between the electrodes above the Curie temperature [48]. Due to the difficulty
of that process, this portion of the work was finished off by a manufacturer. I did not consider
this option because I did not want to use a PZT manufacturer for customization of any portion of
my project based on the correspondences I had with them in terms of pricing and minimum
quantity requirements. An alternate approach was to purchase pre-made, ready to use PZTs
elements, which are available in discs, rods, and cylinders at set frequencies. My solution was to
use premade PZT discs to build a curved phased array. This gave me the flexibility of
determining my transducer dimensions and the curved shape I needed to geometrically achieve
the desired focal region, without going over budget.
4.3. PZT Material Considerations
I used the company STEMiNC because of their wide selection of PZT disc frequencies
and sizes. I purchased ten PZT discs for $29.00 with the desired specifications of low frequency
(kHz range) and small diameter (5.0 mm x 0.4 mm). A common PZT material type is called
PZT-4, which is a type of Navy I PZT and is considered to be a material with “hard”
characteristics. When operating at resonance, most PZT elements will generate heat, however
this class of PZT elements has a very low loss factor, making it a good candidate for low power
consumption [48],[55],[75]. Other parameters to consider for PZTs are their d-coefficients, gcoefficients, piezoelectric coupling factor k, and the dielectric constant ε (F/m). Materials used
for vibrational applications, such as actuators, have higher d-coefficient values. Materials that
produce voltage in response to mechanical stress, such as sensors, have higher g-coefficient
values. The electromechanical effect is characterized by the piezoelectric coupling factor k. The
charge from the voltage is stored on the electrode material and is measured by dielectric constant
ε (F/m). The PZT element I purchased is a modified version of PZT-4. It has higher dcoefficients, higher k value, higher ε, and lower g-coefficients, as seen in Table 1. These
properties are ideal because my LIFU device is not a sensor and I want to maximize the
vibrational effects for ultrasound intensity.
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4.4. Matching Network Considerations
It was specified by the manufacturer that the PZT elements would be within ±10 kHz of
450 kHz. It would be unrealistic to expect nine PZT elements, for the price of $29.00, to have the
exact same piezoelectric qualities or for those impedance values to not change after being
incorporated into the transducer. Even though the PZTs were not exactly at the target resonance
frequency, I still took impedance measurements at 450 kHz because that was the frequency I ran
all of my experiments at.
From the impedance values, Christian and I were able to calculate the ideal capacitor and
inductor values from a code he wrote in MATLAB. Table 8 shows all of the potential capacitor
and inductor values that could be used for each PZT element. Table 3 represents the four
potential combinations of those values. Having a matching network made up of only inductors
(Case 4) consumed too much space and was expensive. On the other hand, a matching network
made up of only capacitors (Case 3) could not achieve a narrow enough bandwidth for the
desired frequency. Case 1 configuration is a low pass filter and Case 2 configuration is a high
pass filter. Both cases can be beneficial because a high pass filter will reduce the effects of
unwanted DC drifts and a low pass filter will reduce the effects of harmonic distortion. Between
Case 1 and Case 2 I selected Case 2 as the dominating matching network design because I had
more size and price options for the inductors with lower values. The benefit of having multiple
configurations to choose from was evident when I ran into a logistical issue with the PZT ID A3.
I ran out of inductors at the value of 75µH. Instead of ordering more inductors, I improvised by
designing that specific matching network using the Case 1 configuration values with a 1.2 nF
shunt capacitor and an 82 µH series inductor. The efficiency of the matching network was not
compromised by the switch from Case 1 to Case 2.
I consulted with Jack Williams, Chris Quinkert, and Jay Shah about the desired
parameters for my inductors and capacitors. I wanted a high voltage and current rating for my
reactive components and a higher tolerance to conserve the matching network benefits. Final
parameters were set based on prices. I chose a tolerance of 5% for the capacitors and a tolerance
of 20% for the inductors. The price and size of inductors increased with the tolerance, so a 20%
tolerance was selected as a compromise between price and specificity. The inductors were the
largest component on the board, with the largest being 8 mm x 8 mm x 4 mm, so I chose the rest
of the components for the matching and amplification network to be less than this package size.
The total amount spent on the SMD components is listed in Table 6. A full breakdown of the unit
prices for the SMD components can be found in Table S4 and Table S5. With Christian’s code I
was able confirm that my purchased component values achieved a matching network that was
within ±5 kHz of the target resonance frequency. Figure 14 is a graphical representation of the
efficiency of one of the PZT element’s matching network with respect to the target resonance
frequency. I further characterized my matching network by using SWR and Γ to calculate the
percentage of power being delivered from the source to the load (Table 9). All of my matching
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networks were calculated to have a power transfer efficiency of at least 99%. All of the values
used to fully characterize the matching networks are reported in Table S1.
4.5.

Prototyping Design Considerations

In all, I fabricated two prototypes before the final third prototype was made. Throughout
the trial and error process of building each prototype, I developed design and fabrication
methods that proved invaluable for the success of the final iteration, referenced as the LIFU
device. The results from these two prototypes are presented in the Supplementary portion of this
document.
4.5.1. Prototype I
The first prototype I built contained PZT elements that had a diameter and thickness of
7.0 mm x 0.03 mm and operated at a resonance frequency of 300 kHz. These elements are
offered with or without wires. The pre-wired elements had wires jutting out from the side of the
element as shown in Figure 23 which was not ideal for building a phased array with the elements
closely packed. Therefore, with spatial considerations in mind, I decided to purchase the
elements without wires and put them on myself. According to the STEMiNC website, wires
could be manually attached under precise soldering conditions: using at least 2% silver content
solder material and soldering within 2 seconds at a temperature of 250 to 270°C (STEMiNC).
However, my attempts to follow the listed instructions resulted in failure. Alternately, I used a
soldering iron to quickly tap the solder and set it. Although this worked, the heat had drastically
changed the PZT element’s original impedance. I then purchased silver conductive epoxy
adhesive that would set without the need for heat (MG Chemicals). Unfortunately, this epoxy
had a long curing time, making it difficult to setup the wires, epoxy, and element to sit overnight.
Even when it was successful, the wires easily detached and also took part of the electrode with it.
While the impedance of the PZTs did not change as drastically as when heat was applied, userhandling of the PZT elements was not feasible for constructing a phased array since the wires
could not handle any strain.

Figure 23: Front and back of PZT element showing wires attached by the company
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It was important to find any other fabrication issues throughout the process, so for the
first prototype with the larger PZT elements and wires I soldered on I moved forward with
constructing the device. I next encountered troubles while creating the silicone backing layer. I
hand mixed the silicone and poured it into the back of the device. The poor mixing resulted in
uncured silicone as well as large air pockets due to the material being too viscous to flow into
tighter areas. This prototype did not initially have a matching layer of epoxy. I was unsure of
how to proceed with achieving a specific concave thickness of epoxy. Instead, a protective
covering of thin latex was placed over the transducer head to protect the PZTs and their electrical
connections during testing in water. However, the PZT elements began to turn brown. The
difference in color can be seen in Figure 24. After consulting with the company, I learned that
this phenomenon was due to oxidation of the silver electrode surface. They said this did not
affect the performance. Once more of the PZT elements began to discolor, I applied an arbitrary
layer of epoxy over the PZTs to quickly protect them from the environment. I knew the
importance of protecting the electrical connections from the water when testing, but I had not
accounted for oxidation.

(a)

(b)

Figure 24: Prototype I. (a) Design of transducer without protective epoxy layer. (b) Finished prototype
with protective epoxy layer and matching network.

The matching network was fabricated based on values I recorded from the PZTs after
wires were soldered to them, but before they were secured into the transducer head. Instead of
treating the transducer as a phased array, I instead had a pin out for each PZT element and its
respective matching network. I wanted to evaluate how each PZT performed. The recorded peak
to peak voltage amplitude values were very weak. This poor signal was likely due to two
reasons: damage via heat exposure and having air as the medium for the ultrasound to travel
from the PZTs to the hydrophone. Although not all the PZTs worked, the ones that did work
emitted signals that were stronger with the epoxy layer than without. The values I recorded can
be found in the Table S6. Overall, prototype I provided me with valuable insight on the nuances
of the fabrication process.
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4.5.2. Prototype II
The second prototype was constructed using disc-shaped PZT elements with a diameter
and thickness of 5.0 mm x 0.4 mm and a resonance frequency of 450 kHz. Additionally, for this
prototype, I ordered the pre-wired PZT elements. Upon the arrival of the PZTs, I made sure to
always handle them with gloves on and kept them in individual bags, only to be taken out for
measurement or fabrication. This was to minimize oxidation of the PZT elements, even though
the company assured me the oxidation would not affect performance. I then measured their
impedance values. Unfortunately, all of the pre-made PZT elements that arrived within the same
batch of ten had varying Z and theta values. The variability was even greater between the PZT
elements that had wires attached by the company. This variability was expected and can be
attributed to impurities in the raw material that cause changes in PZT properties during the
sintering process [39]. Within the same lot the elastic properties can vary by 5%, piezoelectric
properties can vary by 10% and the dielectric properties can vary by 20% [39]. The variability
between the PZT elements with wires attached was compounded by the additional heat this batch
was exposed to during the soldering process. However, the differences within the PZT elements
would not be an issue for the overall phased array design because the matching networks
compensated for the varying impedances. Furthermore, the large difference in Z and theta values
between the PZTs seen in Table 7 did not yield a large difference in matching network values.
Referencing Table 9, there is little difference between the inductor and capacitor values, which
logistically is ideal when ordering components.
Since the PZT elements behaved sensitively to various fabrication processes, I decided to
measure the PZT elements’ impedances after the transducer was fully constructed with the
backing and matching layers. Although heat was not applied at any point in the construction
process, the material properties of the PZT can still be affected. Specifically, silicone and epoxy
have shown to have a capacitive effect on the material properties of the PZT, which can be
attributed to the PZT being pre-loaded by polymer shrinkage. This was determined after
discussion with the company about the change in the PZT impedances. The equivalent circuit for
the PZT element values went from being inductive to capacitive, which changed how the
matching network was calculated for. Specifically, the phase of the PZTs changed from positive
to negative, but the resonance frequency of each PZT remained within ±10 kHz of the
manufacture-specified resonance frequency. After constructing the transducer head, I waited a
few days before measuring the PZT elements’ impedances again to see if there was a significant
drift over time. Based on the new values I collected, none of the PZT elements’ matching
networks needed to be changed. A comparison of the change in a PZT’s impedance and
calculated matching network values upon arrival, immediately set in the transducer, and a week
after being set in the transducer is provided in Table S7. These results showed the importance of
knowing when to measure the PZT impedance for calculations that pertain to the matching
network.
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For the backing and matching layers I consulted with Dan Pederson and Jesse Somann on
how to create the negative mold putty and how to properly mix the silicone and epoxy. They
suggested I use mixing tips to ensure equal parts were mixed, no air was introduced into the
material, and detailed application of the material due to the tip. It was especially important for
the epoxy to have no air bubbles because they would impede the path of the ultrasound.
However, with the addition of the wires sticking straight out from the PZT elements, I
was unable to bend the wires back to snugly fit the PZTs into the slots on the transducer head. To
avoid wasting the 3D-printed concave disc, I used a Dremel to grind the edges of the component,
making notches that the wires could freely jut out from. The modified transducer with the PZT
element wires is shown in Figure 25.
When creating the epoxy matching layer, I ran into more issues when I tried placing my
mold putty negative over the top of the transducer. When testing my fabrication procedure for
the matching layer, the result shown in Figure 6, I did not account for wires coming out of the
sides of the transducer. The wires were blocking the negative from achieving the specific fit
necessary for the 0.8 mm thickness. I tried cutting away as much of the side of the mold putty
that used to hug the side of the transducer for a secure fit. However, the wires proved too big of
an issue and, upon removal of the negative, no epoxy set in the center portion of the transducer. I
went back and manually applied epoxy to fill in the large air bubble region. At the end of the
process there was an epoxy layer over the PZT elements, but it was much thicker than the desired
quarter wavelength thickness.

Figure 25: Prototype II and Dremel job

Moving forward with testing, I used a signal generator with an attached gain of 29 dB. I
set it at 450 kHz and varied the location and amplitude of the hydrophone. At 10 mm away from
the transducer edge with the signal generator set at 0 dBm I was able to pick up a signal. This
confirmed that I was on the right track for achieving my design goals.
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4.5.3. Prototype III
For the final design, I updated the 3D printed concave disc to have notches to compensate
for the wires (Figure 4). Kevin Buno helped me with redesigning and printing the transducer
with notches and molds used to create an updated negative mold putty component. I cut notches
out of my negative mold putty to accommodate the wires and avoid air bubbles from a loose fit.
The evolution of the negative mold putty is shown in Figure 26. I had no issues with applying or
with setting the silicone and epoxy due to the use of mixing tips. The matching network was
based on the final PZT element impedance measurements once they were fully incorporated into
the transducer.

Figure 26: Mold Putty Negatives

The new addition to this prototype was the amplification network. I consulted a lot with
Jack Williams, Chris Quinkert, and Jay Shah for this portion of the project. They helped me
generate a list of search parameters to use when navigating Digi-Key. I wanted a SMD RF power
amplifier that could operate in a low frequency range. SMD RF amplifiers on Digi-Key can cost
hundreds to thousands of dollars. I was able to narrow my search further by incorporating my
cost considerations into the equation. From there I chose the component with the highest gain
and the least amount of additional components for the application circuit as size was a concern.
The current draw from the 5 volt power source ranged from 0.5 A to 0.6 A. The device
consumed 2.5 W to 3.0 W of power. It was difficult to set a specification for this portion of the
design, but this overall power consumption was less than the power consumption of single active
elements in HIFU designs [51], [74], [75], [77]–[79].
4.6. Size and Cost Considerations
Important design specifications for the LIFU device were the consolidation of the
external networks and the overall size of the device. The final PCB board with the matching
network on one side and the amplification network on the other was 50 mm x 57 mm. With the
heat sink and transducer attached the length of the device was 76 mm. Images of the final LIFU
device are shown in Figure 12. For a powerful comparison between the LIFU device and the H115 system, I photographed them together in Figure 13. Both devices are pictured with their
respective transducers, matching networks, and amplification networks. A 6 inch ruler was
included in the picture for reference. The design specification for a small LIFU device was met.
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Another priority for the LIFU device was the price. Again, a comparison between the two
systems was based on the transducer, matching network, and amplifier. The H-115 transducer
and matching network together cost $4,250 (Table 5). The coupling cone, which needs to be
paired with a stereotactic frame for precision focusing, costs $685. The amplifier which was
borrowed from Dr. Hugh Lee’s lab costs $4,900. The total cost for this system comes close to
$10,000. Even with the 5% academic discount offered by many of these companies, this is a high
price to overcome without a grant. Systems like this one are also not customizable. The signal
input and amplitude can be varied. However, the diameter and resonance frequency of the PZT
element and the frequency range of the amplifier are set.
The total cost for the LIFU device was $232.84, while the in-house total cost was $80.94
(Table 6). This distinction was made because some of the materials were already available in the
CID lab. These materials, such as the $100 silicone, can easily be substituted for cheaper
alternatives. For example, I was able to find a silicone of similar properties available in a 400 mL
cartridge for $20.00 (Smooth-On). CID and Purdue University’s biomedical engineering
department also had rapid prototyping tools available for student use, such as the 3D printer and
milling machine. Both of these processes can be easily outsourced at a reasonable price.
Regardless of these stipulations, the cost to build and customize the LIFU device is achievable
for any research group. The design specification for an affordable LIFU device was met.
4.7. Intensity Considerations
When I characterized my device I varied the amplitude and location. Figure 15 shows an
8 mm x 20 mm 2D intensity field calculated from the data collected by the hydrophone. I used a
function generator set at a 450 kHz sine wave and a – 3 dBm amplitude. I started my
measurements at the center of the transducer and moved by 2 mm increments to 20 mm in the z
axis. I moved 4 mm in both directions from the center of the transducer in the x axis. Closest to
the transducer face there is an increased intensity due to the proximity to the PZT elements. The
intensity had a slight increase at 4 mm and then reached peak intensity at a further distance away
from the transducer, representing the focal region. A similar trend and location for the focal
region were simulated in MATLAB in Figure 3. This was a success because the trends measured
accurately characterized the general expected shape for an FUS beam. At certain parameters the
beam will achieve a focused region some distance away from the transducer face. Furthermore,
the measured focal region location matches the simulated focal region location from the
transducer edge. This indicates that I was able to mimic the shape of a curved PZT element with
a geometrically focused phased array to achieve my design specification for the focal length. It is
also important to note the need for deionized water and a rubber lined container. The deionized
water is safer to work with because of its lack of conductivity. The rubber lined container
decreased the likelihood of echoes effecting the hydrophone measurements.
To investigate the future of beam steering for future iterations I disconnected three of the
PZT channels. The FUS beam was created from constructive and destructive ultrasound waves
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and when I introduced an imbalance in the transducer the focal region shifted by
8 mm (Figure 16). I created a shifted 10 mm x 20 mm 2D intensity map using the same
frequency and amplitude parameters I used for the center focused intensity map. The recorded
focal region was 1 mm x 1 mm and occurred between 10 mm and 14 mm. Beam steering is
typically achieved using time delays to influence the location, size, and intensity of the focal
region.
To further characterize the center focused focal region identified in Figure 15, I selected a
region of interest and varied the amplitude from – 6 dBm to 9 dBm. The region of interest
occurred 10 mm to 12 mm from the center of the transducer and is 2 mm x 3 mm. I chose
-6 dBm as the minimum amplitude because no focal region appeared at lower amplitudes. I
chose 9 dBm as the maximum amplitude because the amplifiers have a maximum RF input
power of 12 dBm. It is not advised to operate near or at the maximum limit. Based on the shape
and location of the FUS beam, I selected -3 dBm as the amplitude for my animal studies. I
wanted to ensure that the vagus was receiving therapy, so I chose a larger focal region than the
other focal regions of 0.5 mm x 1 mm achieved at the varying amplitudes (Figure 17). At this
amplitude the focal region is about 1 mm x 4 mm occurring between 10 mm and 12 mm from the
edge of the transducer. The instantaneous intensity at the focal region is 38 mW/cm2.
The potential issue with my FUS beam is that I did not pulse the signal. When testing
prototype II I used a signal generator that was set to output a 450 kHz sine wave at varying
amplitudes represented in dBm. When characterizing and comparing my device I used my
Prototype II results as a point of reference and in doing so mimicked those parameters with the
function generator for the rest of my work. In terms of customization, a greater instantaneous
intensity can be achieved because the maximum input amplitude that the amplifiers can take is
12 dBm. Researchers can easily calculate a desired ISPTA from the instantaneous intensity and
apply it to their experiments. I also chose to not go above -3 dBm because I wanted to achieve a
therapeutic response in the animal study, while balancing device longevity and power
consumption concerns. Researchers in LIFU studies used pulsed signals to mechanically
stimulate the nerve, but the parameters in terms of frequency, intensity, and pulsed signal vary
across the board [68], [87], [89]–[93]. The parameters I selected may not be traditional, but I was
able to induce a therapeutic response in the animal study.
4.8. Surgical and Statistical Considerations
4.8.1. Animal Exclusion Criteria
A total of twelve rats received VNS therapy and are designated with the label FUS. Based
on the cost of rats, housing fee, time and resources twelve rats was the maximum amount of
experiments my team and I could perform. Four rats were removed from the analysis based on
events I recorded in their surgical logs. The LPS was not premade for FUSx002 – FUSx005. We
were using the last of the LPS bought for other experiments. The manual method for making the
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5mg/mL LPS solution involved weighing LPS, adding the saline, and then sonicating for 30
minutes before injection. The issue with this method was that the LPS was very light, making it
difficult to measure out small quantities on the scale of milligrams. These difficulties contributed
to the issue of not making enough LPS due to time constraints. FUSx003 was removed because I
did not make enough LPS that day and had to go remake it, but since I was behind schedule (for
blood collections) the LPS was not sonicated for the full 30 minutes. Once the first blood
collection is taken the timeline is strict. If a time point is missed the experiment cannot be
completed. For FUSx010, when the LPS was injected, a liquid bubble formed at the injection
site. This is indicative of a failed IP injection and this event did not occur for any of the other
animals. For FUSx007, oxygen was not being supplied to the correct nosecone. This was
corrected when the heart rate dropped. Then, between the fifth and sixth blood collection, the rat
stopped breathing twice and had to be revived. I threw out FUSx012, because the breathing was
elevated (340 – 380 bpm) throughout the experiment. It was observed that the rat was not
responding well to the anesthesia. We chose to exclude these animals from the analysis based on
the surgical log recordings and past experience with animal work involving ket/xyl and LPS.
4.8.2. Analysis of TNF-α Concentration
LPS was first injected at time point “0 minutes.” No blood was taken at this time point,
so an elevated response is not visible until time point “30 minutes.” The average concentration of
TNF-α for the control data and the FUS data was plotted in Figure 18. We wanted to determine
the peak of the TNF-α concentration and analyze at that specific time point because this is where
the effect of the therapy will be the most evident and effective. The average control data showed
a peak value at time point “90 minutes.” The error bars also need to be considered. There is no
overlap of the error bars at time point “90 minutes.” At later time points of “120 minutes” and
“150 minutes,” the difference between replicates dramatically increased. This observed
variability was due to these later time points being outside of the linear region on the calibration
curve used for extrapolating cytokine concentrations. In flow cytometry, measurements are less
reliable outside of the linear region. The average difference in replicates at time point “90
minutes” was approximately 100 pg/mL with a maximum value of 380 pg/mL. The average
difference in replicates at the later time points ranged from 400 to 500 pg/mL with a maximum
value of 2,300 pg/mL. For time point “150 minutes” for uRx023 the average difference between
the two replicates was 7,400 pg/mL. This data point was a clear outlier and was removed from
the data.
To further support evaluating at time point “90 minutes” we conducted a Cohen’s h
analysis. We used Cohen’s h to measure the difference between the two proportions and to
determine if the difference was meaningful. Cytokine data for IL-6, IL-10 and TNF-α was
available for all of the FUS rats and most of the control rats. IL-10 data was missing for two of
the controls. We normalized the data based on the total proportion of cytokines measured at each
time point. We then solved for the Gaussian distributed center log ratio for each cytokine. The
average for the control data and FUS data were plotted against each other in Figure 19. For a
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Cohen’s h analysis a meaningful difference is represented as small (greater than 0.2), medium
(greater than 0.5), and large (greater than 0.8). The meaningful differences recorded occurred at
time points “60 minutes” and “90 minutes” with a difference between the control and FUS data
of 0.63 and 0.47, respectively (Table 10). The error bars also do not overlap at time point “90
minutes”.
We next performed a two-sample t-test with an α = 0.05 between the controls and the rats
that received the LIFU device therapy at time point “90 minutes.” The P value was 0.0845,
which meant that the results were not statistically significantly different. Reasons for no response
from the rats could be that the transducer was not placed correctly and these rats did not receive
the full therapy. Another reason could be that these rats had an inflammation response to the LPS
that the therapy could not overcome.
The results of this type experiment will either indicate that the rat did or did not respond to
the therapy. If the rat does respond to the therapy there are varying degrees to how the TNF-α
concentration is affected. When the rat does not respond to the therapy these values mimic
control values and will heavily influence the overall data. Although the results were not
statistically significantly different, there is an observable trend in Figure 20. When comparing
individual rats to the average concentration of the controls there appears to be a therapeutic
response. Comparing each rat against the control, five of the eight rats appeared to respond to the
therapy.
4.8.3. Studentized Residuals
It was suggested by Hakeem to conduct an evaluation of the studentized residuals to
identify which of the rats that did not respond to the therapy. Residuals represent the error
between the predicted value and the actual values. The standard error between each of the
residuals will vary, so the residual values are divided by an estimate of its standard deviation.
This is called the studentized residuals and these values can be used to detect outliers in the
data [100],[101]. Each data point will have a certain amount of leverage on the overall data set.
The average leverage of a data set is represented as 1. The general rule is to double this value and
use that as a cutoff threshold for data points that have a large amount of leverage on the data set.
When the studentized residual value is positive it is an overestimate and when it is negative it is
an underestimate. Another important measurement is the Cook’s Distance (Cook’s D), which
represents a cutoff threshold for outliers [100]. Another general standard is to use 0.5 or 1 as a
cutoff. However, when there are minimal observations another option is to set the cutoff at the
value of four divided by the number of observations.
The first pass of studentized residual calculations, shown in Table S2, yielded an
overestimate for FUSx005 at 2.08. For FUSx005 its TNF-α concentration at time point “90
minutes” is greater than four out of the five controls (Figure 20). This value meets the ±2.0
threshold for removal and was one of the FUS data sets identified worth investigating based on
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domain knowledge. Domain knowledge is in reference to us knowing that some of the rats did
not respond to the therapy and will instead mimic control data. Looking at the Cook’s D and
leverage plots in Figure S1, we determined that this FUS data point had considerable influence
on the overall data. We removed FUSx005 and then performed a two-sample t-test on the
remaining control and FUS data. The P value was 0.0274. The results are statistically
significantly different.
We then recalculated the studentized residuals and also identified FUSx009, with a value
of 2.3, as a rat that did not respond to the therapy (Table S3). We performed another two-sample
t-test on the remaining control data and FUS data. The P value was 0.0062. The results remained
statistically significantly different. All of the diagnostic plots for each calculation are located in
the supplementary section (Figure S1, Figure S2, Figure S3). No more studentized residual
calculations were conducted because no more FUS data points were above cutoff thresholds. The
shape of the QQ-plots and histogram plots further supports the removal of the two FUS data
points. The final histogram plot has a clear normal distribution, whereas the preceding two did
not. After removing the data points that were having a significant effect on the overall data, the
diagnostic plots convey a constant variance and normal distribution, which means that our
assumptions and inferences are valid (Figure S3). When the therapy was determined effective; its
effect was shown to be statistically significantly different from the controls. This is motivation
enough to further investigate the effect of the LIFU device on the modulation of cytokines and to
fine-tune the stimulation parameters used.
Overall, it is well known that there is inherent variability in animal studies. As such, it
was important to conduct many experiments to account for physiological variables. It would
have been interesting to apply other types of stimulation parameters; however I was unable to do
this due to the time and resources required for conducting animal studies and processing data.
Instead, I used the time and resources I had and prioritized statistical power by increasing the
number of replicates.
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4.9. Future Considerations
Future work for this project would be to continue to consolidate and incorporate the
larger aspects of the setup. I was able to eliminate the need for an expensive amplifier. However,
there is always room for improvement in the amplification stage. Biomedical technologies
prioritize power transfer efficiency and take advantage of this aspect by sacrificing linearity,
which is usually important in circuit design [63]. Non-linear amplifiers, such as Class D and E
amplifiers, use two transistors that operate as switches to handle the output stage when no signal
is present. This class of amplifiers also has very low power dissipation and high power
capabilities [63]. However, many of the Class D amplifiers are for audio usage and have optimal
efficiency when their load impedance matches the standard impedance of speakers, which is
typically 4, 8, or 16 ohms [102]. The risk of using this type of amplifier in my system is because
it consists of reactive components. Modern technology employs resistive components, such as
transistors, so impedance mismatching is not as detrimental because the systems are more robust
and can handle power reflection and heat generation [103]. Christian and I had looked into
building our own amplifiers, but decided purchasing an off-the-shelf product was best for this
prototype, as the focus of the project was LIFU and not amplifier design. For the future of this
project I want the efficiency of the amplification stage to be further explored.
The next step would be to electronically steer the FUS beam and focal region. Instead of
manually disconnecting channels, a field programmable gate arrays (FPGAs) could be
incorporated onto the PCB board that would create the desired time delays associated with a
specific focal distance [63]. The FOCUS MATLAB code I used to geometrically calculate the
ROC I needed for my transducer also has the capability to calculate those phase values.
Future animal studies would involve applying a variety of intensities to the vagus nerve.
It would be interesting to investigate and characterize the bimodal effect of excitation and
suppression through signal parameter variations. Another aspect of the animal study that can be
expanded on is removing physiological based LPS variability in the study. For example, for the
first phase of the experiment the rat would be injected with LPS and have blood collections taken
at the same time points. The rat would then be given time to recover and for the second phase of
the experiment the LIFU device therapy would be applied. The results from the first phase of the
experiment could be compared against the results from the second phase of the experiment. This
would eliminate the issues that pertain to the differing inflammatory responses to LPS between
rats that have been measured. The long term goal of this application for animal studies would be
incorporating ultrasound imaging to find the vagus and based on that location use the LIFU
device to stimulate. With the combined use of ultrasound imaging, the noninvasive capability of
the LIFU device could truly be tested in chronic animal studies.
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5. CONCLUSIONS

Research has shown a correlation between depression and the inflammatory response.
VNS is a form of therapy that can decrease the inflammatory response through the modulation of
cytokines. Two forms of stimulation that are commonly investigated are electrical and LIFU.
Cuffing the nerve to achieve electrical stimulation has various side effects, such as damaging the
nerve. The solution is to use FUS to stimulate the nerve without touching it. However, the price
range for FUS systems is in the thousands. In response to the lack of affordable and customizable
FUS systems, I designed my own LIFU device. My main design considerations were for cost and
size. The final LIFU device design is composed of a transducer, matching network, and
amplification network.
Unable to find a curved PZT element, which most LIFU studies employ in their research,
I constructed my own geometrically focused phased array. I applied my own backing and λ/4
thickness matching layer to create the transducer. I incorporated matching networks into the
design that have a power transfer efficiency of at least 99%. An amplification network was built
in to eliminate the need for an industrial sized amplifier that can cost thousands of dollars. I
presented a detailed outline for the fabrication process and a list of off the shelf materials used.
With the resources available in my lab, I was able to build a 50 mm x 57 mm x 76 mm device for
$81.00. The LIFU device consumes 2.5 W to 3 W of power and can achieve an instantaneous
intensity of up to 350 mW/cm2 at 10 mm to 12 mm away from the transducer. I also showed that
this device is capable of beam steering by manually disconnecting channels to shift the location
of the focal region by 8 mm.
I conducted an animal study investigating the therapeutic effect of my LIFU device on a
rat model of the inflammation response. The concentration of the pro-inflammatory cytokine,
TNF-α, was collected and analyzed. Based on a two-sample t-test with an α = 0.05 there was no
statistical significance between the controls and the treatment group. However, it was observed
that five rats out of the eight rats had lowered concentrations at the time point of analysis than
the control. I worked with a statistics consultant to identify data points with a large leverage.
Based on studentized residuals, we removed two FUS rats that did not respond to therapy. When
the therapy was determined effective; its effect was shown to be statistically significantly
different from the controls. The results indicate that there is merit to this form of therapy. Future
work will involve more animal work and applying different stimulation parameters.
As biomedical equipment becomes larger and more advanced, increasing costs become a
major barrier to research. I have created a device and a fabrication process that is repeatable and
customizable for any research group. The size of the LIFU device is a step in the direction
towards wearable technology. The low cost of the LIFU device can be used to expand research in
the field of neuromodulation.
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SUPPLEMENTARY INFORMATION

Table S1: Calculated values for matching network efficiency
PZT
A1
A2
A3
B1
B2
B3
C1
C2
C3

Complex
ZL
55.0139 +
6.848i
47.0180 +
-1.818i
51.5685 +
-6.760i
45.5316 +
0.403i
46.1425 +
-9.727i
52.7301 +
4.729i
49.5924 +
5.723i
52.4808 +
-3.987i
46.6006 +
-4.976i

ZL

SWR

Γ

Return
Loss
(dB)

Reflection
Loss (dB)

Power
Reflected
(%)

Power
Delivered
(%)

55.438

1.11

0.0516

25.750

0.012

0.266

99.734

47.053

0.94

-0.0304

30.353

0.004

0.092

99.908

52.010

1.04

0.0197

34.110

0.002

0.039

99.961

45.533

0.91

-0.0468

26.604

0.010

0.219

99.781

47.157

0.94

-0.0293

30.673

0.004

0.086

99.914

52.942

1.06

0.0286

30.880

0.004

0.082

99.918

49.922

1.00

-0.0008

62.099

0.000

0.000

100.000

52.632

1.05

0.0256

31.820

0.003

0.066

99.934

46.866

0.94

-0.0324

29.800

0.005

0.105

99.895
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Table S2: SAS 94 generated studentized residual data for the FUS and control rats at the time point “90
minutes.” The data FUSx005 has the largest residual studentized value and is above +2.0.

Table S3: SAS 94 generated studentized residual data for the kept FUS and control rats at the time point
“90 minutes.” The data for FUSx009 has the largest residual studentized value and is above +2.0.
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(a)

(b)
Figure S1: SAS 94 generated figures based on data. (a) P value of 0.0845. (b) The fit diagnostics.
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(a)

(b)
Figure S2: SAS 94 generated figures based on data with removed FUSx005. (a) P value of 0.0274. (b)
The fit diagnostics.
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(a)

(b)
Figure S3: SAS 94 generated figures based on data with removed FUSx005, and FUSx009. (a) P value of
0.0062. (b) The fit diagnostics show a normal distribution and constant variance. These plots support that
the assumptions and inferences are valid.
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Table S4: Matching Network Components
Value
Size
0.1 nF
603
1.2 nF
603
1.3 nF
603
1.5 nF
603
1.6 nF
603
68 µH 6.00 x 6.00 x 4.50
75 µH 8.00 x 8.00 x 4.00
82 µH 7.80 x 7.00 x 5.50

Rating Tolerance (%) Unit Price ($)
50 V
5%
0.03
50 V
5%
0.14
50 V
5%
0.13
50 V
5%
0.11
50 V
5%
0.27
1.1 A
20 %
0.47
1.2 A
20 %
0.90
1.2 A
10%
0.63

Table S5: Amplification Network Components
Value
Size
0.1 µF
603
1.0 µF
603
33 µH
7.80 x 7.80 x 5.30
0Ω
402
Amplifier
4.50 x 4.15 x 1.50
Heatsink forged
19.00 x 19.00 x 12.70
w/ adhesive tape

Rating Tolerance (%) Unit Price ($)
50 V
10%
0.19
50 V
10%
0.11
1.2 A
10%
0.55
N/A
N/A
0.01
N/A
N/A
1.88
N/A

N/A

5.66

Table S6: Measured Vpp values for Prototype I without and with epoxy layer of arbitrary thickness
PZT
A1
A2
A3
B1
B2
B3
C1
C2
C3

Vpp (mV)
Without Epoxy With Epoxy
20.50
46.70
5.55
13.06
5.30
10.00
9.32
34.00
5.65
58.00
12.04
17.00
8.47
8.00
9.07
34.00
7.69
8.00
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Table S7: Measured impedance values for one PZT element with wires upon arrival, immediately after
being incorporated into transducer, and one week after being incorporated into transducer
Z (ohms) Theta (degrees) Shunt (BL) Series (XC)
Arrival
458.60
54.40
114 µH
1.84 nF
Transducer
676.00
-32.17
62.8 µH
1.83 nF
Post One Week
633.07
-40.69
61.2 µH
1.79 nF

